PUBLICATIONS AND PresentationS
Discover the main highlights of our industry in our latest publications.
Quick links
Presentation
Publication
Key Economic & Value Considerations in the US
Market for PPTs
Market for PPTs
Key Economic & Value Considerations for PDMPs
in Europe
in Europe
Plasma donation: New thinking to serve Europe’s patients -- Practices & approaches for countries
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Dec 23, 2025
Source plasma apheresis and plasma derived medicinal products: A historical review
Outlines the historical development of plasma-derived medicinal products (PDMPs) and source plasma. This article takes the reader through the major milestones that have shaped the plasma industry, dating back to late 1800s, when Dr. Emil von Behring earned the first Nobel Prize in Medicine for proving that antibodies in serum could neutralize disease and lays the foundation for therapies that would later transform modern medicine.
All
Publication
https://aob.amegroups.org/article/view/11932/pdf
Dec 23, 2025
Source plasma apheresis and plasma derived medicinal products: A historical review
Outlines the historical development of plasma-derived medicinal products (PDMPs) and source plasma. This article takes the reader through the major milestones that have shaped the plasma industry, dating back to late 1800s, when Dr. Emil von Behring earned the first Nobel Prize in Medicine for proving that antibodies in serum could neutralize disease and lays the foundation for therapies that would later transform modern medicine.
All
Publication
https://aob.amegroups.org/article/view/11932/pdf
Dec 23, 2025
Source plasma apheresis and plasma-derived medicinal products: a historical review
All
Publication
https://aob.amegroups.org/article/view/11932/pdf
Dec 23, 2025
Source plasma apheresis and plasma-derived medicinal products: a historical review
All
Publication
https://aob.amegroups.org/article/view/11932/pdf
Dec 1, 2025
Understanding Reimbursement and Access Policies for Immunoglobulins and Other Plasma-Derived Medicinal Products (PDMPs) Across Europe
Against the backdrop of ongoing EU-level initiatives to improve the availability of critical medicines and strengthen supply chain resilience, this study aimed to map the overall PDMP policy landscape and key access dimensions, including reimbursement coverage, cost-containment measures, and stockpiling policies across Europe.
All
Publication
https://cdn.prod.website-files.com/6916f1777886bb3b9377a752/692dc8aeef30fe0ee32993ed_Understanding%20Reimbursement%20and%20Access%20Policies%20for%20Immunoglobulins%20Across%20Europe.pdf
Dec 1, 2025
Understanding Reimbursement and Access Policies for Immunoglobulins and Other Plasma-Derived Medicinal Products (PDMPs) Across Europe
Against the backdrop of ongoing EU-level initiatives to improve the availability of critical medicines and strengthen supply chain resilience, this study aimed to map the overall PDMP policy landscape and key access dimensions, including reimbursement coverage, cost-containment measures, and stockpiling policies across Europe.
All
Publication
https://cdn.prod.website-files.com/6916f1777886bb3b9377a752/692dc8aeef30fe0ee32993ed_Understanding%20Reimbursement%20and%20Access%20Policies%20for%20Immunoglobulins%20Across%20Europe.pdf
Apr 9, 2025
Who are US Source Plasma donors? Results from a preliminary analysis
All
Publication
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jca.70014
Apr 9, 2025
Who are US Source Plasma donors? Results from a preliminary analysis
All
Publication
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jca.70014
No results found